The DOI matches its Crossref record.
Treatment of Corticosteroid-Responsive Autoimmune Inner Ear Disease With Methotrexate: A Randomized Controlled Trial
Abstract
CONTEXT: A number of therapies have been proposed for the long-term management of corticosteroid-responsive, rapidly progressive, bilateral sensorineural hearing loss (autoimmune inner ear disease [AIED]). Methotrexate has emerged as the benchmark agent but has not been rigorously evaluated for hearing improvement in patients with AIED. OBJECTIVE: To assess the efficacy of long-term methotrexate in maintaining hearing improvements achieved with glucocorticoid (prednisone) therapy in patients with AIED. DESIGN, SETTING, AND PARTICIPANTS: A randomized, double-blind, placebo-controlled trial conducted from February 3, 1998, to November 5, 2001, of 67 patients with rapidly progressive, bilateral sensorineural hearing loss at 10 tertiary care centers in the United States. INTERVENTION: Randomization to either oral methotrexate (15 to 20 mg/wk; n = 33) or placebo (n = 34), in combination with an 18-week prednisone taper. Follow-up examinations, including audiometric evaluation, were performed at 4, 8, 12, 24, 36, 48, and 52 weeks, or until hearing loss was documented. MAIN OUTCOME MEASURE: Maintenance of hearing improvement achieved from prednisone treatment. RESULTS: Sixty-seven patients (57.8%) enrolled in the prednisone challenge experienced hearing improvement. Twenty-five patients (37%) experienced hearing improvements in both ears. Of the individuals who reached study end points, 24 (80%) of 30 end points were because of measured hearing loss in the methotrexate group and 29 (93.5%) of 31 end points were because of measured hearing loss in the placebo group (P =.15). Methotrexate was no more effective than placebo in maintaining the hearing improvement achieved with prednisone treatment (hazard ratio, 1.31; 95% confidence interval, 0.79-2.17; P =.30). CONCLUSION: Methotrexate does not appear to be effective in maintaining the hearing improvement achieved with prednisone therapy in patients with AIED.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cunningham, L. L., & Tucci, D. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1616601 · Cited by 599
Sudden sensorineural hearing loss
Schreiber, B. E., Agrup, C., Haskard, D. O., & Luxon, L. M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62071-7 · Cited by 554
Primary Sjögren's syndrome: new clinical and therapeutic concepts
Ramos-Casals, M., Tzioufas, A. G., & Font, J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025676 · Cited by 295
Intratympanic steroids for sensorineural hearing loss
Rauch, S. D. (2004) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2004.04.004 · Cited by 88
Self-citation
Metadata
- Authors
- Harris, J. P., Weisman, M. H., Derebery, J. M., Espeland, M. A., Gantz, B. J., Gulya, A. J., Hammerschlag, P. E., Hannley, M., Hughes, G. B., Moscicki, R., Nelson, R. A., Niparko, J. K., Rauch, S. D., Telian, S. A., & Brookhouser, P. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-10-08
- Volume
- 290
- Issue
- 14
- Pages
- 1875
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2145920349
- Cited by
- 179
- References
- 0
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Corticosteroid-Responsive Autoimmune Inner Ear Disease With Methotrexate: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1001/jama.290.14.1875
- The paper
- Harris, J. P., Weisman, M. H., Derebery, J. M., Espeland, M. A., Gantz, B. J., Gulya, A. J., Hammerschlag, P. E., Hannley, M., Hughes, G. B., Moscicki, R., Nelson, R. A., Niparko, J. K., Rauch, S. D., Telian, S. A., & Brookhouser, P. E. (2003). Treatment of Corticosteroid-Responsive Autoimmune Inner Ear Disease With Methotrexate: A Randomized Controlled Trial. JAMA. https://doi.org/10.1001/jama.290.14.1875
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.